Do fewer males present to clinical high-risk services for psychosis relative to first-episode services?

Early Intervention in Psychiatry

Volumn 11, Issue 5, 2017, Pages 429-435

  Wilson, Robin P ^a   Patel, Rashmi ^a   Bhattacharyya, Sagnik ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

demography; male; mental disorder; prodromal symptoms; psychotic disorder

Indexed keywords

ADULT; ARTICLE; CLINICAL HIGH RISK SERVICE; CONTROLLED STUDY; ENGLAND; FEMALE; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; SEX DIFFERENCE; SEX RATIO; AUSTRALIA; EUROPE; MENTAL HEALTH SERVICE; MENTAL STRESS; PSYCHOLOGY; RISK FACTOR; SEX FACTOR; THERAPY; UTILIZATION; YOUNG ADULT;

ADULT; AUSTRALIA; EUROPE; FEMALE; HUMANS; LONDON; MALE; MENTAL HEALTH SERVICES; PSYCHOTIC DISORDERS; RISK FACTORS; SEX FACTORS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84958213227     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12311     Document Type: Article

References (53)

1. Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry 2000; 34: S164–169.
2. Fusar-Poli P, Bonoldi I, Yung AR et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220–229. PubMed PMID: 22393215. eng.
3. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 2011; 132: 8–17.
4. Nelson B, Yuen H, Wood SJ et al. Long-term follow-up of a group at ultra high risk (‘prodromal’) for psychosis: the pace 400 study. JAMA Psychiatry 2013; 70: 793–802.
5. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. British Medical Journal 2013; 12: 14. 28.
6. Addington J, Cornblatt BA, Cadenhead KS et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800–805. PubMed PMID: 21498462. Pubmed Central PMCID: PMC3150607. eng.
7. Simon AE, Borgwardt S, Riecher-Rössler A, Velthorst E, de Haan L, Fusar-Poli P. Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis. Psychiatry Res 2013; 209: 266–272. PubMed PMID: 23871169. eng.
8. Yung AR, Yuen HP, Berger G et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33: 673–681.
9. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 2014; 40: 120–131. PubMed PMID: 23180756. Pubmed Central PMCID: PMC3885287. eng.
10. van Os J, Linscott RJ. Introduction: the extended psychosis phenotype – relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophr Bull 2012; 38: 227–230.
11. Fusar-Poli P, Bechdolf A, Taylor MJ et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 2013; 39: 923–932. PubMed PMID: 22589370. Pubmed Central PMCID: PMC3686446. eng.
12. Eranti SV, MacCabe JH, Bundy H, Murray RM. Gender difference in age at onset of schizophrenia: a meta-analysis. Psychol Med 2013; 43: 155–167. PubMed PMID: 22564907. eng.
13. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003; 28 (Suppl. 2): 17–54. PubMed PMID: 12650680. eng.
14. Salokangas RK, Nieman DH, Heinimaa M et al. Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 303–311. PubMed PMID: 22797132. eng.
15. Walder DJ, Holtzman CW, Addington J et al. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res 2013; 144: 43–50. PubMed PMID: PMC4045468.
16. Chon M-W, Lee TY, Kim SN et al. Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis. Schizophr Res 2015; 162: 64–66.
17. Merikangas KR, He J-P, Burstein M et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010; 49: 980–989.
18. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Special Issue Toward a New Psychobiology of Depression in WomenSex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29: 85–96.
19. Ittig S, Studerus E, Papmeyer M et al. Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects. Eur Psychiatry 2015; 30: 242–250. PubMed PMID: 25555341. eng.
20. Lemos-Giráldez S, Vallina-Fernández O, Fernández-Iglesias P et al. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 2009; 115: 121–129.
21. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in south London (OASIS), 2001–2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry 2013; 28: 315–326. PubMed PMID: 23137782. eng.
22. Nelson B, Yuen H, Wood SJ et al. Long-term follow-up of a group at ultra high risk (‘prodromal’) for psychosis: the pace 400 study. JAMA Psychiatry 2013; 70: 793–802.
23. Ruhrmann S, Schultze-Lutter F, Salokangas RK et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241–251. PubMed PMID: 20194824. Epub 2010/03/03. eng.
24. Schultze-Lutter F, Klosterkotter J, Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 2014; 154: 100–106.
25. Addington J, Cadenhead KS, Cornblatt BA et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res 2012; 142: 77–82.
26. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007; 115: 304–309.
27. DeVylder JE, Muchomba FM, Gill KE et al. Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder. Schizophr Res 2014; 159: 278–283.
28. Addington J, Brooks BL, Addington D. Cognitive functioning in first episode psychosis: initial presentation. Schizophr Res 2003; 62: 59–64.
29. Clarke M, Whitty P, Browne S et al. Suicidality in first episode psychosis. Schizophr Res 2006; 86: 221–225.
30. Henry L, Harris M, Amminger G et al. The EPPIC long term follow-up study of first episode psychosis: methodology and baseline characteristics. Early Intervent Psychiatry 2007; 1: 49–60.
31. Norman RM, Mallal AK, Manchanda R et al. Does treatment delay predict occupational functioning in first-episode psychosis? Schizophr Res 2007; 91: 259–262.
32. Polari A, Lavoie S, Sarrasin P, Pellanda V, Cotton S, Conus P. Duration of untreated psychosis: a proposition regarding treatment definition. Early Intervent Psychiatry 2011; 5: 301–308.
33. Dudley R, Shaftoe D, Cavanagh K et al. Jumping to conclusions' in first-episode psychosis. Early Intervent Psychiatry 2011; 5: 50–56.
34. Segarra R, Ojeda N, Pena J et al. Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: one-year follow-up from the Eiffel study. Eur Psychiatry 2012; 27: 43–49.
35. O'Connor JA, Wiffen B, DiForti M et al. Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study. Schizophr Res 2013; 149: 70–76.
36. Tosato S, Lasalvia A, Bonetto C et al. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J Psychiatr Res 2013; 47: 438–444.
37. Birchwood M, Lester H, McCarthy L et al. The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics. Early Intervent Psychiatry 2014; 8: 59–67.
38. Tarricone I, Boydell J, Panigada S et al. The impact of substance use at psychosis onset on First Episode Psychosis course: results from a 1 year follow-up study in Bologna. Schizophr Res 2014; 153: 60–63.
39. Ittig S, Studerus E, Papmeyer M et al. Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects. Eur Psychiatry 2015; 30: 242–250.
40. Melle I, Larsen TK, Haahr U et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004; 61: 143–150.
41. Patel R, Wilson R, Jackson R et al. Cannabis use and treatment resistance in first episode psychosis: a natural language processing study. The Lancet 2015; 385 (Suppl. 1): S79.
42. Cotton SM, Wright A, Harris MG, Jorm AF, McGorry PD. Influence of gender on mental health literacy in young Australians. Aust N Z J Psychiatry 2006; 40: 790–796. PubMed PMID: 16911755. eng.
43. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res 2011; 129: 29–35.
44. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003; 74: 5–13.
45. McLean CP, Anderson ER. Brave men and timid women? A review of the gender differences in fear and anxiety. Clin Psychol Rev 2009; 29: 496–505.
46. Thorup A, Albert N, Bertelsen M et al. Gender differences in first-episode psychosis at 5-year follow-up – two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry 2014; 29: 44–51.
47. Barnett JH, Werners U, Secher SM et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007; 190: 515–520. PubMed PMID: 17541112. eng.
48. Robinson D, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241–247. PubMed PMID: 10078501. eng.
49. Thompson E, Millman ZB, Okuzawa N et al. Evidence-based early interventions for individuals at clinical high risk for psychosis: a review of treatment components. J Nerv Ment Dis 2015; 203: 342–351.
50. Srihari VH, Shah J, Keshavan MS. Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am 2012; 35: 613–631. PubMed PMID: PMC3431510.
51. Fusar-Poli P, Yung A, McGorry P, Van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med 2014; 44: 17–24.
52. Correll CU, Robinson DG, Schooler NR et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the raise-etp study. JAMA Psychiatry 2014; 71: 1350–1363.
53. Srihari VH, Tek C, Kucukgoncu S et al. First-episode services for psychotic disorders in the U.S. public sector: a pragmatic randomized controlled trial. Psychiatr Serv 2015; 66: 705–712. appips201400236. PubMed PMID: 25639994. ENG.